Biosketch / Results /

Alan Werzberger

Clinical Assistant Professor, Department of Pediatrics

Contact Info

845/783-2222

Education

1981 — University of Toronto, Medical Education
— Hospital for Sick Children, Canada, Residency Training
1981-1985 — Hospital for Sick Children, Residency Training

A recessive gene for primary vesicoureteral reflux maps to chromosome 12p11-q13
Weng, Patricia L; Sanna-Cherchi, Simone; Hensle, Terry; Shapiro, Ellen; Werzberger, Alan; Caridi, Gianluca; Izzi, Claudia; Konka, Anita; Reese, Adam C; Cheng, Rong; Werzberger, Samuel; Schlussel, Richard N; Burk, Robert D; Lee, Joseph H; Ravazzolo, Roberto; Scolari, Francesco; Ghiggeri, Gian Marco; Glassberg, Kenneth; Gharavi, Ali G. A recessive gene for primary vesicoureteral reflux maps to chromosome 12p11-q13. Journal of the American Society of Nephrology. 2009 May 14;20(7):1633-1640 (126465)

Safety, tolerability and immunogenicity of VAQTA given concomitantly versus nonconcomitantly with other pediatric vaccines in healthy 12-month-old children
Guerra, Fernando A; Gress, Jacqueline; Werzberger, Alan; Reisinger, Keith; Walter, Emmanuel; Lakkis, Hassan; Grosso, Anthony D; Welebob, Carolee; Kuter, Barbara J. Safety, tolerability and immunogenicity of VAQTA given concomitantly versus nonconcomitantly with other pediatric vaccines in healthy 12-month-old children. Pediatric infectious disease journal. 2006 Oct ;25(10):912-919 (94288)

The safety and immunogenicity of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children: a study of manufacturing consistency and persistence of antibody
Lieberman, Jay M; Williams, Wendy R; Miller, Jacqueline M; Black, Steven; Shinefield, Henry; Henderson, Frederick; Marchant, Colin D; Werzberger, Alan; Halperin, Scott; Hartzel, Jonathan; Klopfer, Stephanie; Schodel, Florian; Kuter, Barbara J. The safety and immunogenicity of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children: a study of manufacturing consistency and persistence of antibody. Pediatric infectious disease journal. 2006 Jul ;25(7):615-622 (94289)

Effectiveness of hepatitis A vaccine in a former frequently affected community: 9 years' followup after the Monroe field trial of VAQTA
Werzberger, Alan; Mensch, Barbara; Nalin, David R; Kuter, Barbara J. Effectiveness of hepatitis A vaccine in a former frequently affected community: 9 years' followup after the Monroe field trial of VAQTA [Letter]. Vaccine. 2002 Mar 15;20(13-14):1699-1701 (36429)

Six years' follow-up after hepatitis A vaccination
Werzberger A; Kuter B; Nalin D. Six years' follow-up after hepatitis A vaccination [Comment]. New England journal of medicine. 1998 Apr 16;338(16):1160-1160 (23387)